Clinical Trial Update: Metformin and Simvastatin in Addition to Fulvestrant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the addition of metformin and simvastatin to fulvestrant in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• SIMVASTATIN (SIMVASTATIN)
• metformin (metformin)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN